<?xml version="1.0" encoding="UTF-8"?>
<p>Modulation of the RAAS axis is central to the management of cardiovascular disease [
 <xref rid="C62" ref-type="bibr">62</xref>]. Cardiovascular disease, heart failure, atrial fibrillation, and kidney disease are associated with elevated levels of ACE2 [
 <xref rid="C60" ref-type="bibr">60</xref>]. It is critical to discern if these elevations are a culprit or sequelae of disease in order to separate association from causation [
 <xref rid="C63" ref-type="bibr">63</xref>]. More recent opinions suggest ACE2 represents as a biomarker, rather than a culprit, of cardiovascular disease [
 <xref rid="C64" ref-type="bibr">64</xref>].
</p>
